IRMD Average Annual Return Since 2014
Growth of $10,000.00
With Dividends Reinvested Into IRMD


Also see:
IRMD stock yearly return 2015
IRMD stock yearly return 2016
IRMD stock yearly return 2017
IRMD stock yearly return 2018
IRMD stock yearly return 2019
IRMD stock yearly return 2020
IRMD stock yearly return 2021
IRMD stock yearly return 2022
IRMD stock yearly return 2023
IRMD YTD return
Compare IRMD average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 07/17/2014
End date: 05/17/2024
Start price/share: $9.00
End price/share: $42.03
Starting shares: 1,111.11
Ending shares: 1,186.82
Dividends reinvested/share: $2.83
Total return: 398.82%
IRMD Average Annual Return: 17.74%
Starting investment: $10,000.00
Ending investment: $49,885.03


IRMD average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
iRadimed develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible medical devices and accessories, disposables and services relating to them. Co. provides MRidium 3860+ MRI compatible intravenous (IV) infusion pump system with related disposable IV tubing sets, 3880 MRI compatible patient vital signs monitoring system with related disposable products, and 3600 FMD1 with Remote Alarm Logging Unit ferromagnetic detection device. Co.'s MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, proprietary single-use IV tubing sets, a non-magnetic pole and a lithium battery. The IRMD average annual return since 2014 is shown above.

The Average Annual Return on the IRMD average annual return since 2014 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether IRMD average annual return since 2014 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the IRMD average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree IRMD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
iRadimed (IRMD) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

IRTC Average Annual Return
IRWD Average Annual Return
ISPC Average Annual Return
ISRG Average Annual Return
ITCI Average Annual Return
ITGR Average Annual Return
ITOS Average Annual Return
IVVD Average Annual Return
JAGX Average Annual Return
JAN Average Annual Return
More Healthcare companies »

 

IRMD Average Annual Return Since 2014 | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.